Takeda

Oshi Health is a virtual-first gastroenterology clinic focused on diagnosing, treating, and remotely monitoring digestive health conditions. The clinic offers a comprehensive approach by integrating a team of gastroenterologists, specialized nurse practitioners, registered dietitians, behavioral psychologists, and health coaches. This collaborative team helps patients identify the root causes of their symptoms and develops personalized care plans that incorporate medication, dietary changes, and gut-brain behavioral therapy. By prioritizing accessibility and patient experience, Oshi Health aims to improve clinical outcomes and enhance the overall quality of life for individuals suffering from gastrointestinal issues.

Oshi Health is a virtual-first gastroenterology clinic focused on diagnosing, treating, and remotely monitoring digestive health conditions. The clinic offers a comprehensive approach by integrating a team of gastroenterologists, specialized nurse practitioners, registered dietitians, behavioral psychologists, and health coaches. This collaborative team helps patients identify the root causes of their symptoms and develops personalized care plans that incorporate medication, dietary changes, and gut-brain behavioral therapy. By prioritizing accessibility and patient experience, Oshi Health aims to improve clinical outcomes and enhance the overall quality of life for individuals suffering from gastrointestinal issues.

Oshi Health is a virtual-first gastroenterology clinic focused on diagnosing, treating, and remotely monitoring digestive health conditions. The clinic offers a comprehensive approach by integrating a team of gastroenterologists, specialized nurse practitioners, registered dietitians, behavioral psychologists, and health coaches. This collaborative team helps patients identify the root causes of their symptoms and develops personalized care plans that incorporate medication, dietary changes, and gut-brain behavioral therapy. By prioritizing accessibility and patient experience, Oshi Health aims to improve clinical outcomes and enhance the overall quality of life for individuals suffering from gastrointestinal issues.

Oshi Health is a virtual-first gastroenterology clinic focused on diagnosing, treating, and remotely monitoring digestive health conditions. The clinic offers a comprehensive approach by integrating a team of gastroenterologists, specialized nurse practitioners, registered dietitians, behavioral psychologists, and health coaches. This collaborative team helps patients identify the root causes of their symptoms and develops personalized care plans that incorporate medication, dietary changes, and gut-brain behavioral therapy. By prioritizing accessibility and patient experience, Oshi Health aims to improve clinical outcomes and enhance the overall quality of life for individuals suffering from gastrointestinal issues.

Oshi Health is a virtual-first gastroenterology clinic focused on diagnosing, treating, and remotely monitoring digestive health conditions. The clinic offers a comprehensive approach by integrating a team of gastroenterologists, specialized nurse practitioners, registered dietitians, behavioral psychologists, and health coaches. This collaborative team helps patients identify the root causes of their symptoms and develops personalized care plans that incorporate medication, dietary changes, and gut-brain behavioral therapy. By prioritizing accessibility and patient experience, Oshi Health aims to improve clinical outcomes and enhance the overall quality of life for individuals suffering from gastrointestinal issues.

VHsquared is dedicated to the development of novel antibody domains engineered to be stable in the GI tract. Their novel antibody platform will provide a portfolio of new and innovative functional food products to target gastrointestinal infectious and immune mediated diseases. There has been an explosion of interest in foods that have additional physiological benefits. VHsquared leverages the existing research and expertise at the Sanger Institute to facilitate the development of products that function at the GI mucosal interface harnessing recent technological developments, including analysis of the microbiota and advances in mucosal immunology. Conventional antibodies are degraded in the gut and therefore efficacy obtained from oral administration is limited. VHsquared uses domain antibodies that can be selected and engineered to resist degradation, are intrinsically very stable and are locally active in the gastrointestinal tract. Products will offer advantages in terms of specificity, safety, efficacy, convenience and cost.

Domainex Ltd. is a biotechnology company based in Saffron Walden, United Kingdom, specializing in contract research and contract manufacturing services focused on drug discovery. Established in 2001, the company offers a comprehensive range of services including medicinal chemistry, computational chemistry, protein expression and purification, biochemical assay development, and DMPK analysis. Domainex also employs advanced technologies for hit identification and combinatorial domain hunting. The company is particularly noted for its work in developing innovative treatments for inflammatory diseases, such as DMXD-011, a small-molecule inhibitor targeting TBK1/IKKε/SIK2 for conditions like rheumatoid arthritis and lupus. Through its capabilities in biology and chemistry, Domainex aims to assist healthcare professionals in addressing complex drug discovery challenges, particularly in oncology and related fields.